RENAL CARCINOMA
Clinical trials for RENAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney cancer: drug targets genetic weakness in tumors
Disease control Recruiting nowThis study tests the drug olaparib (a pill) in 20 people with advanced kidney cancer that has spread. To join, your tumor must have a specific gene mutation (like BAP-1 or BRCA). The goal is to see if the drug can shrink or stop tumor growth for at least 6 months. Participants mu…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 05:29 UTC
-
New drug cocktail aims to shrink kidney tumors before surgery
Disease control Recruiting nowThis study tests whether the drug casdatifan, alone or with zimberelimab, can safely shrink kidney tumors before surgery. It is for adults with a specific type of kidney cancer (clear cell renal cell carcinoma) that is large or has spread. The goal is to see if the treatment redu…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Cheaper pain cocktail may beat exparel after kidney surgery
Symptom relief Recruiting nowThis study compares two pain relief methods used during robotic kidney surgery: a cheaper mix of drugs called R.E.C.K and a more expensive option called Exparel. About 170 adults having robotic kidney removal will be randomly assigned to one of the two treatments. Researchers wil…
Matched conditions: RENAL CARCINOMA
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 11:58 UTC